Sarah DiDominick

Affiliations

Translational Clinical Oncology, Novartis Institutes for BioMedical Research (NIBR), Cambridge, Massachusetts, USA.

Publications (2)

A Phase 1 Study of a CDH6-Targeting Antibody-Drug Conjugate in Patients with Advanced Solid Tumors with Evaluation of Inflammatory and Neurological Adverse Events.

Oncology research and treatment

Avec: Patrick Schöffski , Nicole Concin , Cristina Suarez , Vivek Subbiah , Yuichi Ando , Shiling Ruan , Joel P Wagner , Keith Mansfield , Xu Zhu , Shizuka Origuchi , Sarah DiDominick , Carl U Bialucha , Jason E Faris , Ben Tran

Phase Ib/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non-small cell lung cancer.

Lung cancer (Amsterdam, Netherlands)

Avec: Armando Santoro , Wu-Chou Su , Alejandro Navarro , Matteo Simonelli , James Ch Yang , Andrea Ardizzoni , Fabrice Barlesi , Jin Hyoung Kang , Sarah DiDominick , Ahmed Abdelhady , Xueying Chen , Uz Stammberger , Enriqueta Felip

Réseau de co-auteurs

Patrick Schöffski 1 collaboration

Nicole Concin 1 collaboration

Cristina Suarez 1 collaboration

Vivek Subbiah 1 collaboration

Yuichi Ando 1 collaboration

Shiling Ruan 1 collaboration

Joel P Wagner 1 collaboration

Keith Mansfield 1 collaboration

Xu Zhu 1 collaboration

Shizuka Origuchi 1 collaboration

Carl U Bialucha 1 collaboration

Jason E Faris 1 collaboration

Ben Tran 1 collaboration

Armando Santoro 1 collaboration

Wu-Chou Su 1 collaboration

Alejandro Navarro 1 collaboration

Matteo Simonelli 1 collaboration

James Ch Yang 1 collaboration

Andrea Ardizzoni 1 collaboration

Fabrice Barlesi 1 collaboration

Jin Hyoung Kang 1 collaboration

Ahmed Abdelhady 1 collaboration

Xueying Chen 1 collaboration

Uz Stammberger 1 collaboration

Enriqueta Felip 1 collaboration